Jarrow Formulas Releases EPActive For Positive Mental Well-Being*
LOS ANGELES - October 29, 2015 - Jarrow Formulas®, a formulator and supplier of superior nutritional supplements, announces the introduction of EPActive™, a high dose, triglyceride-source EPA formula that is purified to remove heavy metals and toxins. Those seeking to support cardiovascular health,* positive mental well-being,* cytokine balance,* and healthy skin,* may benefit from using EPActive™.
Since the first studies in the 1970s on the cold water fish-based, fat- rich diets of the Greenland Eskimos, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) have been repeatedly recognized for their important role in health.* While these two Omega 3 fatty acids were considered to have interchangeable health benefits in the past, the latest data shows that EPA has clinical applications that are unique and important for both a variety of bodily systems and for long term health.*
Science has shown EPA to support key aspects of cardiometabolic health along with other unique benefits such as positive mood and outlook. In a meta analysis from 2009¹, 28 studies concluded EPA was likely than DHA for positive depression outcomes. A 2011 meta analysis² used 15 trials to conclude omega 3 supplements with EPA making up 60% or more of the total omega 3s were the most effective for depression.*
Jarrow Formulas’ EPActive™ provides 800 mg per gel cap of well- absorbed, triglyceride-based EPA, as found in pure and natural, unrefined fish oil. EPActive™ meets the stringent proposed USP monograph for purity to remove environmental contaminants, heavy metals, such as mercury, and organic toxins, such as dioxins and PCBs. Natural mixed tocopherols are used as antioxidants to protect against lipid peroxidation.
"By supporting both cardiometabolic health as well as positive mood and outlook, EPActive™ provides a wide range of potential benefits both men and women*" says Sky Garmon, Marketing Associate. "EPActive™ was formulated using ample research demonstrating triglyceride-source EPA offering significantly increased absorption and bioavailability than other forms.*"
Jarrow Formulas products can be found at fine health shops and vitamin stores nationwide. For more information, please visit www.jarrow.com.
ABOUT JARROW FORMULAS
Jarrow Formulas is based in Los Angeles, California, and is a formulator and supplier of superior nutritional supplements. The company was founded in 1977 and today it markets its products in the United States and throughout the world. Jarrow Formulas' goal is to promote optimal health based on sound scientific research data. The companyÂ’s complete line of nutritional products includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition products. www.jarrow.com.
JARROW FORMULAS, INC. MEDIA CONTACT:
Rory Lipsky, Senior Director of Business Strategy, Jarrow Formulas
(310) 204-6936
rory@jarrow.com
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
¹J Am Coll Nutr. 2009 Oct;28(5):525-42.
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
²Clin Psychiatry. 2011 Dec;72(12):1577-84. doi: 10.4088/JCP.10m06634. Epub 2011 Sep 6.
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
Sublette ME, Ellis SP, Geant AL, Mann JJ.
Since the first studies in the 1970s on the cold water fish-based, fat- rich diets of the Greenland Eskimos, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) have been repeatedly recognized for their important role in health.* While these two Omega 3 fatty acids were considered to have interchangeable health benefits in the past, the latest data shows that EPA has clinical applications that are unique and important for both a variety of bodily systems and for long term health.*
Science has shown EPA to support key aspects of cardiometabolic health along with other unique benefits such as positive mood and outlook. In a meta analysis from 2009¹, 28 studies concluded EPA was likely than DHA for positive depression outcomes. A 2011 meta analysis² used 15 trials to conclude omega 3 supplements with EPA making up 60% or more of the total omega 3s were the most effective for depression.*
Jarrow Formulas’ EPActive™ provides 800 mg per gel cap of well- absorbed, triglyceride-based EPA, as found in pure and natural, unrefined fish oil. EPActive™ meets the stringent proposed USP monograph for purity to remove environmental contaminants, heavy metals, such as mercury, and organic toxins, such as dioxins and PCBs. Natural mixed tocopherols are used as antioxidants to protect against lipid peroxidation.
"By supporting both cardiometabolic health as well as positive mood and outlook, EPActive™ provides a wide range of potential benefits both men and women*" says Sky Garmon, Marketing Associate. "EPActive™ was formulated using ample research demonstrating triglyceride-source EPA offering significantly increased absorption and bioavailability than other forms.*"
Jarrow Formulas products can be found at fine health shops and vitamin stores nationwide. For more information, please visit www.jarrow.com.
ABOUT JARROW FORMULAS
Jarrow Formulas is based in Los Angeles, California, and is a formulator and supplier of superior nutritional supplements. The company was founded in 1977 and today it markets its products in the United States and throughout the world. Jarrow Formulas' goal is to promote optimal health based on sound scientific research data. The companyÂ’s complete line of nutritional products includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition products. www.jarrow.com.
JARROW FORMULAS, INC. MEDIA CONTACT:
Rory Lipsky, Senior Director of Business Strategy, Jarrow Formulas
(310) 204-6936
rory@jarrow.com
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
¹J Am Coll Nutr. 2009 Oct;28(5):525-42.
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
²Clin Psychiatry. 2011 Dec;72(12):1577-84. doi: 10.4088/JCP.10m06634. Epub 2011 Sep 6.
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
Sublette ME, Ellis SP, Geant AL, Mann JJ.
*These statements have not been evaluated by the Food and Drug Administration. This product is
not intended to diagnose, treat, cure or prevent any disease.
